Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Periodontal Diseases | 5 | 2013 | 54 | 1.330 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2015 | 1085 | 1.020 |
Why?
|
| Oral Health | 3 | 2013 | 49 | 0.850 |
Why?
|
| Insurance Coverage | 2 | 2013 | 99 | 0.750 |
Why?
|
| Periodontitis | 4 | 2018 | 47 | 0.730 |
Why?
|
| Insurance, Health | 2 | 2013 | 201 | 0.720 |
Why?
|
| Dental Care | 1 | 2016 | 34 | 0.550 |
Why?
|
| Chronic Periodontitis | 5 | 2015 | 18 | 0.540 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 84 | 0.530 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2016 | 767 | 0.450 |
Why?
|
| Analgesics, Opioid | 5 | 2019 | 498 | 0.440 |
Why?
|
| Health Services Accessibility | 2 | 2016 | 581 | 0.400 |
Why?
|
| Blood Glucose | 2 | 2016 | 631 | 0.310 |
Why?
|
| Telemedicine | 1 | 2016 | 700 | 0.310 |
Why?
|
| South Carolina | 6 | 2016 | 2752 | 0.300 |
Why?
|
| Practice Patterns, Dentists' | 2 | 2019 | 10 | 0.300 |
Why?
|
| Prescription Drug Diversion | 2 | 2019 | 7 | 0.300 |
Why?
|
| Gingivitis | 3 | 2011 | 16 | 0.280 |
Why?
|
| Prescription Drug Monitoring Programs | 2 | 2018 | 34 | 0.280 |
Why?
|
| Periodontal Attachment Loss | 4 | 2016 | 12 | 0.250 |
Why?
|
| Metabolic Syndrome | 2 | 2018 | 191 | 0.230 |
Why?
|
| Periodontal Pocket | 3 | 2014 | 15 | 0.220 |
Why?
|
| Cross-Sectional Studies | 6 | 2019 | 2279 | 0.200 |
Why?
|
| Oral Hygiene | 2 | 2013 | 33 | 0.200 |
Why?
|
| Medicaid | 2 | 2016 | 302 | 0.200 |
Why?
|
| Community-Based Participatory Research | 2 | 2013 | 133 | 0.190 |
Why?
|
| Medically Uninsured | 2 | 2013 | 99 | 0.190 |
Why?
|
| Gingival Hemorrhage | 2 | 2011 | 10 | 0.190 |
Why?
|
| Middle Aged | 13 | 2016 | 21147 | 0.180 |
Why?
|
| Humans | 24 | 2019 | 68618 | 0.180 |
Why?
|
| Pain Management | 2 | 2019 | 186 | 0.180 |
Why?
|
| Aged | 12 | 2016 | 14862 | 0.170 |
Why?
|
| Adult | 12 | 2016 | 21403 | 0.170 |
Why?
|
| Dentists | 2 | 2019 | 18 | 0.170 |
Why?
|
| CD36 Antigens | 1 | 2018 | 9 | 0.160 |
Why?
|
| Education, Dental | 1 | 2019 | 63 | 0.160 |
Why?
|
| Gingival Crevicular Fluid | 2 | 2016 | 9 | 0.160 |
Why?
|
| Matrix Metalloproteinase 8 | 3 | 2016 | 22 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2019 | 504 | 0.150 |
Why?
|
| Substance-Related Disorders | 2 | 2019 | 1242 | 0.150 |
Why?
|
| Matrix Metalloproteinase 1 | 2 | 2016 | 74 | 0.150 |
Why?
|
| Female | 15 | 2019 | 38074 | 0.150 |
Why?
|
| Acute Pain | 1 | 2018 | 35 | 0.150 |
Why?
|
| Male | 14 | 2019 | 37321 | 0.150 |
Why?
|
| Scleroderma, Systemic | 2 | 2011 | 446 | 0.150 |
Why?
|
| Periodontium | 2 | 2014 | 11 | 0.150 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 167 | 0.140 |
Why?
|
| Body Mass Index | 2 | 2011 | 867 | 0.140 |
Why?
|
| Disease Progression | 2 | 2011 | 1038 | 0.140 |
Why?
|
| Medically Underserved Area | 1 | 2016 | 85 | 0.130 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2015 | 23 | 0.130 |
Why?
|
| Opioid-Related Disorders | 1 | 2019 | 298 | 0.130 |
Why?
|
| Cohort Studies | 2 | 2011 | 2358 | 0.120 |
Why?
|
| United States | 4 | 2016 | 7367 | 0.120 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2014 | 76 | 0.120 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 212 | 0.120 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2014 | 126 | 0.110 |
Why?
|
| Rural Population | 1 | 2016 | 398 | 0.110 |
Why?
|
| Salivary Glands | 1 | 2013 | 52 | 0.110 |
Why?
|
| Exercise Therapy | 2 | 2011 | 183 | 0.110 |
Why?
|
| Cultural Competency | 1 | 2013 | 42 | 0.110 |
Why?
|
| Community-Institutional Relations | 1 | 2012 | 59 | 0.100 |
Why?
|
| Surveys and Questionnaires | 2 | 2019 | 2800 | 0.100 |
Why?
|
| Microstomia | 1 | 2011 | 5 | 0.100 |
Why?
|
| Diabetes Complications | 2 | 2016 | 249 | 0.100 |
Why?
|
| Diabetic Nephropathies | 1 | 2013 | 161 | 0.100 |
Why?
|
| Fear | 1 | 2013 | 239 | 0.100 |
Why?
|
| Needs Assessment | 1 | 2013 | 186 | 0.100 |
Why?
|
| Myofunctional Therapy | 1 | 2011 | 6 | 0.100 |
Why?
|
| Toothbrushing | 1 | 2011 | 21 | 0.100 |
Why?
|
| Dental Devices, Home Care | 1 | 2011 | 17 | 0.100 |
Why?
|
| Universities | 1 | 2012 | 191 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 282 | 0.090 |
Why?
|
| Dental Plaque | 1 | 2010 | 14 | 0.090 |
Why?
|
| Up-Regulation | 3 | 2018 | 682 | 0.090 |
Why?
|
| Income | 1 | 2011 | 167 | 0.090 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 955 | 0.090 |
Why?
|
| Health Personnel | 1 | 2012 | 286 | 0.090 |
Why?
|
| Lipopolysaccharides | 3 | 2018 | 455 | 0.080 |
Why?
|
| Health Status Disparities | 1 | 2013 | 326 | 0.080 |
Why?
|
| Logistic Models | 1 | 2013 | 1420 | 0.080 |
Why?
|
| Health Promotion | 1 | 2013 | 407 | 0.080 |
Why?
|
| Oroantral Fistula | 1 | 2008 | 1 | 0.080 |
Why?
|
| Radicular Cyst | 1 | 2008 | 1 | 0.080 |
Why?
|
| Tooth Socket | 1 | 2008 | 5 | 0.080 |
Why?
|
| Oral Surgical Procedures | 1 | 2008 | 15 | 0.080 |
Why?
|
| Medicare | 1 | 2011 | 319 | 0.080 |
Why?
|
| Dental Implantation, Endosseous | 1 | 2008 | 18 | 0.080 |
Why?
|
| Prevalence | 1 | 2013 | 1619 | 0.080 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 362 | 0.070 |
Why?
|
| Sex Factors | 1 | 2011 | 1266 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2010 | 1054 | 0.070 |
Why?
|
| Interleukin-6 | 1 | 2008 | 330 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2010 | 3259 | 0.070 |
Why?
|
| Age Factors | 1 | 2011 | 1864 | 0.070 |
Why?
|
| Complement C3c | 1 | 2005 | 1 | 0.060 |
Why?
|
| Complement C4b | 1 | 2005 | 3 | 0.060 |
Why?
|
| Complement C3d | 1 | 2005 | 10 | 0.060 |
Why?
|
| Immunoglobulin A | 1 | 2005 | 79 | 0.060 |
Why?
|
| Gingiva | 2 | 2014 | 34 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 1026 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2005 | 481 | 0.050 |
Why?
|
| Smoking | 1 | 2010 | 1452 | 0.050 |
Why?
|
| Tooth Extraction | 2 | 2014 | 27 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 306 | 0.040 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2018 | 48 | 0.040 |
Why?
|
| Palmitates | 1 | 2018 | 20 | 0.040 |
Why?
|
| Hydrocodone | 1 | 2016 | 5 | 0.030 |
Why?
|
| Collagenases | 1 | 2016 | 34 | 0.030 |
Why?
|
| Simvastatin | 1 | 2016 | 34 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2011 | 1553 | 0.030 |
Why?
|
| Lymphocyte Antigen 96 | 1 | 2015 | 10 | 0.030 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2015 | 15 | 0.030 |
Why?
|
| Drug Overdose | 1 | 2016 | 67 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2016 | 160 | 0.030 |
Why?
|
| Macrophages | 1 | 2018 | 647 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2015 | 114 | 0.030 |
Why?
|
| Curriculum | 1 | 2019 | 575 | 0.030 |
Why?
|
| Crown Lengthening | 1 | 2014 | 3 | 0.030 |
Why?
|
| Gingivoplasty | 1 | 2014 | 7 | 0.030 |
Why?
|
| Risk Reduction Behavior | 1 | 2015 | 174 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2015 | 447 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2018 | 902 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 209 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2673 | 0.030 |
Why?
|
| Hypertriglyceridemia | 1 | 2013 | 21 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2013 | 106 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 710 | 0.030 |
Why?
|
| U937 Cells | 1 | 2011 | 61 | 0.020 |
Why?
|
| Dental Plaque Index | 1 | 2011 | 10 | 0.020 |
Why?
|
| Mouth Rehabilitation | 1 | 2011 | 7 | 0.020 |
Why?
|
| Young Adult | 2 | 2016 | 5717 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1664 | 0.020 |
Why?
|
| Tooth | 1 | 2011 | 24 | 0.020 |
Why?
|
| Program Development | 1 | 2012 | 240 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2013 | 737 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2012 | 502 | 0.020 |
Why?
|
| American Dental Association | 1 | 2010 | 1 | 0.020 |
Why?
|
| Prostaglandin Antagonists | 1 | 2010 | 11 | 0.020 |
Why?
|
| Mouthwashes | 1 | 2010 | 9 | 0.020 |
Why?
|
| Chlorhexidine | 1 | 2010 | 12 | 0.020 |
Why?
|
| Terpenes | 1 | 2010 | 18 | 0.020 |
Why?
|
| Salicylates | 1 | 2010 | 22 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 694 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2011 | 158 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2010 | 111 | 0.020 |
Why?
|
| Immunomodulation | 1 | 2010 | 35 | 0.020 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2010 | 40 | 0.020 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2010 | 59 | 0.020 |
Why?
|
| Equipment Design | 1 | 2011 | 500 | 0.020 |
Why?
|
| Drug Approval | 1 | 2010 | 50 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2011 | 7029 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1040 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2010 | 304 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2011 | 402 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2010 | 411 | 0.020 |
Why?
|
| Dental Implants, Single-Tooth | 1 | 2008 | 4 | 0.020 |
Why?
|
| Molar | 1 | 2008 | 27 | 0.020 |
Why?
|
| Bone Substitutes | 1 | 2008 | 20 | 0.020 |
Why?
|
| Research Design | 1 | 2012 | 729 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2011 | 425 | 0.020 |
Why?
|
| Bone Transplantation | 1 | 2008 | 43 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 88 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 689 | 0.020 |
Why?
|
| Membranes, Artificial | 1 | 2008 | 88 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 240 | 0.020 |
Why?
|
| RNA | 1 | 2008 | 171 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 492 | 0.020 |
Why?
|
| Obesity | 1 | 2013 | 1076 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 626 | 0.020 |
Why?
|
| Complement Pathway, Classical | 1 | 2005 | 22 | 0.020 |
Why?
|
| Antigens | 1 | 2005 | 90 | 0.020 |
Why?
|
| Biological Transport | 1 | 2005 | 210 | 0.020 |
Why?
|
| Hypertension | 1 | 2013 | 1535 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 507 | 0.010 |
Why?
|
| Adolescent | 1 | 2016 | 8912 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 1047 | 0.010 |
Why?
|
| Quality of Life | 1 | 2011 | 1515 | 0.010 |
Why?
|
| Risk Factors | 1 | 2013 | 5731 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 4655 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 4848 | 0.010 |
Why?
|